2025 first_quarter Filing

FEROX STRATEGIESforUnknown

Filed

March 18, 2025

View Original Document

Lobbying Activities

Health IssuesView all

Policy and oversight related to generic and biosimilar industry issues.

PharmacyView all

Policy and oversight related to generic and biosimilar industry issues.

Lobbyists (3)

CRISTINA ANTELO

Legal Fellow, Senate Democratic Steering Committee.

New

MARK WILLIAMS

Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson.

New

MICHAEL TAGGART

Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director

New

Foreign Entities

FRESENIUS KABI SWISSBIOSIM GMBH

CH0Ownership: 100%